Cargando…
Retrospective Analysis of Patients with Signet Ring Subtype of Colorectal Cancer with Peritoneal Metastasis Treated with CRS & HIPEC
SIMPLE SUMMARY: Approximately 1% of all patients with colorectal cancer, and 15% of patients with peritoneal metastasized colorectal cancer present with the subtype of signet ring cell, which is associated with inferior oncological outcome and reduced overall survival. The evidence whether patients...
Autores principales: | Prabhu, Aruna, Brandl, Andreas, Wakama, Satoshi, Sako, Shouzou, Ishibashi, Haruaki, Mizumoto, Akiyoshi, Takao, Nobuyuki, Noguchi, Kousuke, Motoi, Shunsuke, Ichinose, Masumi, Liu, Yang, Yonemura, Yutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565458/ https://www.ncbi.nlm.nih.gov/pubmed/32906609 http://dx.doi.org/10.3390/cancers12092536 |
Ejemplares similares
-
Neoadjuvant Intraperitoneal Chemotherapy in Patients with Pseudomyxoma Peritonei—A Novel Treatment Approach
por: Prabhu, Aruna, et al.
Publicado: (2020) -
Long Term Survival after Cytoreductive Surgery Combined with Perioperative Chemotherapy in Gastric Cancer Patients with Peritoneal Metastasis
por: Yonemura, Yutaka, et al.
Publicado: (2020) -
Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study
por: Kamada, Yasuyuki, et al.
Publicado: (2021) -
Effect of oxaliplatin‐based chemotherapy on chemosensitivity in patients with peritoneal metastasis from colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: proof‐of‐concept study
por: Prabhu, A, et al.
Publicado: (2021) -
The Development of Peritoneal Metastasis from Gastric Cancer and Rationale of Treatment According to the Mechanism
por: Yonemura, Yutaka, et al.
Publicado: (2022)